Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids
- 1 October 1996
- journal article
- Published by Elsevier in Kidney International
- Vol. 50 (4) , 1255-1261
- https://doi.org/10.1038/ki.1996.435
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Erythropoietin enhances vascular responsiveness to norepinephrine in renal failureKidney International, 1995
- Direct evidence for erythropoietin-induced release of endothelin from peripheral vascular tissueLife Sciences, 1994
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Venous smooth muscle contains vasoconstrictor ETB-like receptorsBiochemical and Biophysical Research Communications, 1992
- Influence of Recombinant Human Erythropoietin on Platelet Function and Coagulation FactorsBlood Purification, 1992
- Direct vasopressor effect of recombinant human erythropoietin on renal resistance vesselsKidney International, 1991
- Intracellular Signaling Pathway of Endothelin-1Journal of Cardiovascular Pharmacology, 1991
- ERYTHROPOIETIN, HAEMOGLOBIN, AND HYPERTENSIVE CRISESThe Lancet, 1988
- BLOOD PRESSURE, ERYTHROPOIETIN, AND NITRIC OXIDEThe Lancet, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987